Glycemicon
Glycemicon`s efforts are focused on the discovery, development and commercialization of innovative.
Based based in Europe, Middle East, and Africa (EMEA), Glycemicon works in biotechnology, nutraceutical, founded in 2013.
Glycemicon is positioned in biotechnology, nutraceutical, a segment that rewards a clear, focused offering.
Its base of operations is Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_A stage.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $5.2M.
| Sector | Biotechnology, Nutraceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2013 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $5,160,000 |
Website: glycemicon.com
Sign in to view the contact information we hold for Glycemicon.
Create a free account
Create a free account